Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4XS | ISIN: CNE1000002V2 | Ticker-Symbol: ZCH
Stuttgart
14.11.24
08:24 Uhr
0,515 Euro
+0,010
+1,98 %
Branche
Telekom
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA TELECOM CORP LTD Chart 1 Jahr
5-Tage-Chart
CHINA TELECOM CORP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,5200,54011:02
PR Newswire
370 Leser
Artikel bewerten:
(2)

China Telecom: 5G-A Builds a Dedicated Air Bridge for Smart Healthcare

Finanznachrichten News

BEIJING, Nov. 13, 2024 /PRNewswire/ -- Currently, there are two pain points in the transportation of medical materials: slow response to urgent medical needs and unbalanced medical resource allocation.

According to statistics, three people in the world need a blood transfusion every second. In China, more than 6 million patients need blood transfusions every year. Limited by traffic conditions, traditional blood transportation usually takes a long period of time. Additionally, medical resources are unevenly distributed in urban and rural areas, making it difficult for patients from rural areas to seek medical treatments in urban hospitals, especially for those with mobility impairments. For example, residents in Hongtong Village in Hangzhou, Zhejiang Province had to spend several hours on taking medical checks in the Second People's Hospital of Yuhang District.

To address this issue, A third-class hospital in Zhejiang cooperated with Hangzhou Antwork Network Technology Co., Ltd. to transport blood with UAVs. By carrying out numerous tests, verifications, and test flights, they have accumulated extensive experience and successfully established a channel in air for blood transportation. UAVs are flexible, fast, autonomous, and not affected by road conditions, demonstrating great significance in the field of medical emergencies. The success of the three parties marks the use of the first regular UAV route for emergent blood delivery in China. Currently, Hangzhou has established multiple blood delivery routes, creating the world's first city-level regular blood delivery system.

To further combine the flexible and efficient advantages of UAVs with medical services, China Telecom has proposed the world's first super air-ground convergence technology.

  1. The air-ground integrated smart beamforming technology is used to support integrated beam coordination and ground-to-air coverage, achieving 3.5 GHz low-altitude coverage in urban areas.
  2. New large-angle smart antennas that support power sharing are used to realize low-altitude coverage in suburban areas based on the wide coverage of 2.1 GHz bandwidth.

The world's first super air-ground convergence technology was released during MWC Shanghai 2024. This technology forms an efficient ground-to-air private network, achieving continuous coverage at low altitudes.

In addition, sensing application services (AS), sensing functions (SF), and base station sensing devices form a high-precision medical sensing network. The network supports functions such as complex UAV trajectory analysis, geo-fence, and multi-object detection at the precision within one meter, escorting medical channels in air in real time.

A Builds a Dedicated Air Bridge for Smart Healthcare


Using these innovative technologies and devices, the low-altitude network features high bandwidth and low latency and meets the 4K HD video backhaul requirements of UAVs. Medical resource delivery with UAVs is fast, flexible, and will not be affected by ground traffic conditions or weather conditions (scale-5 wind resistance). The transportation efficiency is improved by 60%, ensuring 24-hour instant response to urgent blood requests. The actual flight data indicates that the blood volume delivered per flight can meet the emergency use of one or two patients, while the transportation time per flight is just half of ground transportation under the same conditions, ensuring both "emergency blood use" and "planned blood replenishment."

These technologies have also established more UAV highways from towns to towns, building a bridge between the central hospital of the medical consortium and the grassroots healthcare centers, and providing great support for the implementation of the hierarchical diagnosis and treatment system. For example, a patient can leave a blood sample in a community hospital, which will be delivered to the detection center through the UAV. In dozens of minutes, the detection result will be available. This greatly improves the efficiency of medical treatments for the public.



According to Antwork, its UAV logistics scheduling system has been fully integrated with the smart medical platform of several large third-class hospitals in Zhejiang. This integration not only forms a closed service loop, but also provides technical assurance for blood transportation, making it one of the most advanced medical practices with UAVs in the world.

The cooperation between China Telecom, Antwork, and the hospital is a historic milestone, as it signifies the recognition of UAV technology in clinical healthcare. The dedicated UAV route will provide more assurance for emergency rescue and save more patients' lives. Delivering medical resources with UAVs is gaining recognition in the healthcare industry.

Photo - https://mma.prnewswire.com/media/2556424/A_Builds_a_Dedicated_Air_Bridge_Smart_Healthcare.jpg
Photo - https://mma.prnewswire.com/media/2556425/image_5032577_27268449.jpg
Photo - https://mma.prnewswire.com/media/2556426/1.jpg
Photo - https://mma.prnewswire.com/media/2556427/2.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/5g-a-builds-a-dedicated-air-bridge-for-smart-healthcare-302304135.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.